AMPCO-PITTSBURGH CORP (AP) Spending and interest coverage
- R&D / revenue · 12 months: Value (m); Formula and calculation Research and development expense / revenue. Period ending 2026-06-30..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-06-30..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | (m) | Research and development expense / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | (m) | Research and Development Expense |
| Revenue | 409.16M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | -47.62M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $409.16M | (m) | $-47.62M | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | (m) | $420.19M | (m) | $-55.77M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $494.00K | $416.28M | $1.35M | $-54.48M | (m) | 0.12% | 0.32% | (m) | (m) |
| 2025-09-30 | (m) | $409.60M | (m) | $7.07M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $397.93M | (m) | $7.82M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $392.00M | (m) | $15.94M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $441.00K | $402.80M | $1.48M | $12.17M | (m) | 0.11% | 0.37% | (m) | (m) |
| 2024-09-30 | (m) | $408.93M | (m) | $-34.58M | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $419.06M | (m) | $-34.73M | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $422.96M | (m) | $-36.48M | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $662.00K | $415.32M | $2.15M | $-34.57M | (m) | 0.16% | 0.52% | (m) | (m) |
| 2023-09-30 | (m) | $402.05M | (m) | $7.95M | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $397.08M | (m) | $6.43M | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $390.46M | (m) | $5.22M | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $1.02M | $380.25M | $1.67M | $2.78M | (m) | 0.27% | 0.44% | (m) | (m) |
| 2022-09-30 | (m) | $380.89M | (m) | $-11.78M | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $362.29M | (m) | $-14.07M | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $352.38M | (m) | $-13.28M | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $1.23M | $344.92M | $2.44M | $-13.62M | (m) | 0.36% | 0.71% | (m) | (m) |
| 2021-09-30 | (m) | $347.44M | (m) | $1.02M | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $341.93M | (m) | $3.56M | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $324.28M | (m) | $3.00M | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $2.05M | $328.54M | $1.33M | $6.45M | (m) | 0.62% | 0.40% | (m) | (m) |
| 2020-09-30 | (m) | $338.53M | (m) | $7.49M | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | $353.73M | (m) | $5.97M | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | $381.47M | (m) | $5.40M | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $2.52M | $397.90M | $1.42M | $-10.91M | (m) | 0.63% | 0.36% | (m) | (m) |
| 2019-09-30 | (m) | $396.71M | (m) | $-54.03M | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $404.66M | (m) | $-55.54M | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | $420.51M | (m) | $-55.07M | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $2.66M | $419.43M | $2.12M | $-44.89M | (m) | 0.64% | 0.50% | (m) | (m) |
| 2018-09-30 | (m) | (m) | (m) | $-10.78M | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | $-7.33M | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | $-7.91M | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $3.39M | (m) | $2.40M | $-9.37M | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | $-47.37M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | $-49.09M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | $-51.93M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $2.72M | (m) | $2.33M | $-54.53M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | $-7.05M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | $-4.47M | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | $-418.00K | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $1.14M | (m) | $1.33M | $5.05M | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | $-5.42M | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | $-3.02M | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | (m) | (m) | (m) | $-195.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $1.33M | (m) | $1.10M | $80.00K | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | (m) | (m) | (m) | $6.92M | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | (m) | $27.66M | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | (m) | (m) | (m) | $28.03M | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $1.41M | (m) | $1.20M | $28.97M | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | (m) | (m) | (m) | $30.38M | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | $13.35M | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | (m) | (m) | (m) | $13.89M | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $1.48M | (m) | $1.26M | $16.29M | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | $1.46M | $17.79M | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | $1.66M | $17.87M | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | $28.46M | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | $1.95M | $36.47M | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | (m) | (m) | $3.27M | $24.73M | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | (m) | (m) | $1.81M | $46.73M | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GORMAN RUPP CO (GRC) | United States | $1.969B | 38.90 |
| FLOWSERVE CORP (FLS) | United States | $9.667B | 25.54 |
| GRACO INC (GGG) | United States | $12.488B | 23.77 |
| IDEX CORP /DE/ (IEX) | United States | $16.848B | 32.33 |
| ITT INC. (ITT) | United States | $19.129B | 39.62 |
| Xylem Inc. (XYL) | United States | $23.974B |